Floatz logo

THIOGUANINE ANHYDROUS

Philadelphia Chromosome Positive

Children's Oncology GroupSmall moleculePhase 3Dormant
B
62/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
89/ 100

Competitive context

20 Active assets in the Philadelphia Chromosome Positive cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
City of Hope Medical Center
Phase 3BB
Cytosin-Arabinosid
M.D. Anderson Cancer Center
Phase 3BB
VINCRISTINE SULFATE
M.D. Anderson Cancer Center
Phase 3BB
Blinatumomab
M.D. Anderson Cancer Center
Phase 2BB
DEXAMETHASONE
M.D. Anderson Cancer Center
Phase 3BB

View all 28 →

Same molecule, other indications

THIOGUANINE ANHYDROUS is also rated in:

B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
73 / 100
View asset →
acute lymphoblastic leukemiaDormant
BBB
Indicative ·
72 / 100
View asset →
lymphoblastic lymphomaDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →